Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

Shivam Puri, CEO, Cipla Health, discusses the brand proposition of Prolyte ORS, shares strategy that helped brand achieve Rs ...

Indian shares fell on Wednesday, dragged down by high weightage financials and as drugmaker Cipla extended its post-results ...

On technical setup, the scrip traded higher than the 5-day, 10-, 150-day and 200-day simple moving averages (SMAs) but lower ...

Cipla's strong recovery came after the US Food and Drug Administration concluded inspection at its Goa facility with ...

Shares of pharmaceutical giant Cipla dipped 5 per cent at Rs 1,403 per share on the NSE in Wednesday's intraday deals: Cipla ...

Cipla Q2 Results Live : Cipla declared their Q2 results on 29 Oct, 2024, showcasing a robust performance with a topline ...

Cipla Ltd, a major player in the Indian pharmaceutical sector, currently trades at ₹1,418. This price reflects a decrease of ...

Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 companies in the NSE Nifty today on ...

Join us on the Cipla Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in ...

Mumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has ...

Cipla Limited reports strong financials with highest-ever EBITDA margin, despite slower domestic growth, maintaining market ...